AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19637415
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination of lopinavir and ritonavir
Trial: 27376466
Drug: TNF‐α inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNF‐α inhibitors
Trial: 14702268
Drug: Citalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10 mg)
Trial: 29029131
Drug: AA infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AA infusion
Trial: 22123096
Drug: Oral 9-THC
RxNorm normalized name: delta-9-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 9-THC 10 mg QID
Trial: 24661235
Drug: 1.8 mL
RxNorm normalized name: insulin pump syringe, 1.8 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 mL of 4% articaine with 1 : 100 000 epinephrine
Trial: 24661235
Drug: 3.6 mL
RxNorm normalized name: ALCOHOL 2.7 mL in 3.6 mL TOPICAL CLOTH [hand sanitizers]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 mL of 4% articaine with 1 : 100 000 epinephrine
Trial: 24661235
Drug: 1.8 mL
RxNorm normalized name: insulin pump syringe, 1.8 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 mL of 4% articaine with 1 : 100 000 epinephrine (initial IANB)
Trial: 12949684
Drug: Impaza (antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impaza (antibodies to endothelial NO synthase in ultralow doses)
Trial: 11004016
Drug: Growth hormone-releasing
RxNorm normalized name: Growth hormone-releasing peptide 2
DrugBank: Pralmorelin (DB18252)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Growth hormone-releasing peptide-2 (1 microg/kg)
Trial: 11004016
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of L-arginine and growth hormone-releasing peptide-2
Trial: 31678060
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBMT) with 940nm, 2.5W, 120s, 85.71J/cm2, 0.89W/cm2, three times per week for two weeks (G1)
Trial: 31678060
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBMT) with 940nm, 4.1W, 120s, 68.33J/cm2, 0.58W/cm2, three times per week for two weeks (G2)
Trial: 19812066
Drug: Intra-partum single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-partum single-dose nevirapine
Trial: 16901024
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection into the musculature adjacent to the wound
Trial: 16901024
Drug: Placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injection into the musculature adjacent to the wound
Trial: 15293866
Drug: Solifenacin 10
RxNorm normalized name: solifenacin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 10 mg (oral)
Trial: 30005748
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of level overlap and color coding
Trial: 17186726
Drug: Drug cupping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug cupping therapy (DCT) with Liuwei Dihuang Pill (LDP)
Trial: 17186726
Drug: Common cupping
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common cupping therapy without drug
Trial: 1289921
Drug: Intramuscular desipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular desipramine (DMI) 75 mg
Trial: 6549160
Drug: Allopurinol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (20 mg/kg/day orally for 3 days)
Trial: 31883766
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline administered at the same rate for the same duration
Trial: 19678557
Drug: Spiritual-hypnosis assisted
RxNorm normalized name: Spiritus vini
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spiritual-hypnosis assisted therapy (SHAT)
Trial: 31560227
Drug: Bulking laxative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bulking laxative and probiotic
Trial: 31560227
Drug: Osmotic laxative
RxNorm normalized name: HYPEROSMOTIC LAXATIVES
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osmotic laxative
Trial: 27317162
Drug: L-carnitine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (1000 mg/d)
Trial: 19036981
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of the selective NE‐reuptake inhibitor reboxetine (RBX)
Trial: 10807817
Drug: salbutamol inhalation
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: salbutamol inhalation via pMDI
Trial: 10807817
Drug: salbutamol inhalation
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: salbutamol inhalation via pMDI + spacer
Trial: 10807817
Drug: placebo inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo inhalation
Trial: 10807817
Drug: salbutamol inhalation
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: salbutamol inhalation via Autohaler
Trial: 8614273
Drug: ENA 713
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ENA 713 12 mg/day bid (n=20)
Trial: 1940775
Drug: Lovastatin treatment
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin treatment
Trial: 29544728
Drug: BGF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BGF MDI 80/14.4/10 μg
Trial: 22504462
Drug: 0.01 mg/kg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg/h background infusion plus 0.01 mg/kg bolus (BI)
Trial: 22504462
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg bolus-only morphine (B0)
Trial: 20480794
Drug: Onion extract
RxNorm normalized name: Onion Extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onion extract gel (OE)
Trial: 20480794
Drug: 0.5% hydrocortisone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% hydrocortisone, silicone and vitamin E lotion (HSE)
Trial: 17638395
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 40 mg once daily
Trial: 17638395
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg once daily + Hydrochlorothiazide 12.5 mg once daily
Trial: 17638395
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg once daily (initial treatment)
Trial: 16097995
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg b.d. for 5 days
Trial: 7044013
Drug: Molsidomine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (3 x 2 mg/day)
Trial: 22342506
Drug: Long agonist
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long agonist half-dose protocol
Trial: 22342506
Drug: Short agonist
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short agonist protocol without pretreatment
Trial: 16490579
Drug: IDD-P fenofibrate
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IDD-P fenofibrate 160-mg tablet plus atorvastatin 10-mg tablet
Trial: 16490579
Drug: IDD-P fenofibrate
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IDD-P fenofibrate 160-mg tablet plus simvastatin 10-mg tablet
Trial: 11391844
Drug: MSP (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSP (250 mg mefloquine, 500 mg sulphadoxine, and 25 mg pyrimethamine per tablet)
Trial: 11391844
Drug: CQ (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ (150 mg chloroquine base per tablet)
Trial: 1379523
Drug: Fazarabine (Ara-AC)
RxNorm normalized name: 2-fluoro ARA-A
DrugBank: Fludarabine (DB01073)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fazarabine (Ara-AC) at a dose of 2.00 mg m‐2 h‐1
Trial: 26094591
Drug: Younger age
RxNorm normalized name: AGS-499
DrugBank: AGS-499 (DB18058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Younger age and higher oral HPV16 copy number
Trial: 24274358
Drug: Instaflex™ Joint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instaflex™ Joint Support (3 colored gel capsules per day for 8 weeks)
Trial: 24274358
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 colored gel capsules per day for 8 weeks)
Trial: 21136237
Drug: Insulin Glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin Glargine (GLA)
Trial: 21136237
Drug: Insulin Detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin Detemir (DET)
Trial: 18234045
Drug: eletriptan 40
RxNorm normalized name: eletriptan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 40 mg (E40) and E80
Trial: 10907666
Drug: Olanzapine (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (daily dose: 18.3 mg)
Trial: 10907666
Drug: Sertindole (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertindole (daily dose: 16 mg)
Trial: 10907666
Drug: Typical antipsychotic
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical antipsychotic drugs (n=12)
Trial: 1800390
Drug: Bismuth subnitrate
RxNorm normalized name: Bismuth subnitrate
DrugBank: Bismuth subnitrate (DB13209)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth subnitrate (3 x 700 mg/d)
Trial: 1800390
Drug: Cimetidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1 x 800 mg/d)
Trial: 25866027
Drug: Graded single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Graded single radiation doses with fixation after 24 h (dose-response)
Trial: 18167291
Drug: Traditional pericardial
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional pericardial monocuspid valve patch
Trial: 15451058
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (45 mg zinc as gluconate daily for 8 weeks)
Trial: 8180524
Drug: Tenoxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam (20 mg i.v. injection followed by 20 mg tablet once daily for 6 days)
Trial: 8180524
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (75 mg i.m. injection followed by 50 mg tablet 4 to 6 hours postoperatively and 50 mg three times daily for 6 days)
Trial: 8180524
Drug: Tenoxicam (suggested
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam (suggested 40 mg dose at induction of anesthesia)
Trial: 3540870
Drug: Codeine 60
RxNorm normalized name: codeine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 60 mg at all three doses
Trial: 3540870
Drug: Placebo at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo at all three doses
Trial: 21724341
Drug: Weekly marijuana
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly marijuana users
Trial: 15450839
Drug: New 2-octylcyanoacrylate
RxNorm normalized name: 2-octylcyanoacrylate
DrugBank: 2-octyl cyanoacrylate (DB12040)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New 2-octylcyanoacrylate formulation
Trial: 15450839
Drug: Old 2-octylcyanoacrylate
RxNorm normalized name: 2-octylcyanoacrylate
DrugBank: 2-octyl cyanoacrylate (DB12040)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Old 2-octylcyanoacrylate formulation
Trial: 18787216
Drug: Linezolid (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (600 mg twice daily)
Trial: 11170948
Drug: Vancomycin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (1 g intravenously twice daily)
Trial: 9924006
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg Cu/l (Control)
Trial: 9924006
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg Cu/l
Trial: 9924006
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg Cu/l
Trial: 2318372
Drug: Non-pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-pharmacological treatment consisting of monthly check-ups, home blood pressure measurements, and lifestyle advice (salt restriction, weight reduction, physical activity, reduction of alcohol and tobacco)
Trial: 30640655
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 0.375% ropivacaine (Group A)
Trial: 22727783
Drug: Pre-treatment craving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment craving measured using the Obsessive subscale of the Obsessive Compulsive Drinking Scale
Trial: 22727783
Drug: Pre-treatment depressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment depressive mood
Trial: 20932667
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (ICT) - three cycles of cisplatin-based chemotherapy followed by CHART
Trial: 17401488
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of daclizumab, mycophenolate mofetil (MMF), and prednisone (GII, N = 33)
Trial: 10834687
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered at 8-hr intervals through nasogastric tube)
Trial: 2876326
Drug: Homoeopathic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homoeopathic preparation of mixed grass pollens
Trial: 31755993
Drug: Topical omiganan
RxNorm normalized name: Omiganan
DrugBank: Omiganan (DB06610)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical omiganan 2.5%
Trial: 27571256
Drug: Dexmedetomidine (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (continuous infusion at a rate of 0.1 μg kg h; n = 38)
Trial: 12795572
Drug: Family-focused psychoeducational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused psychoeducational therapy (n = 28)
Trial: 1352930
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg daily for 4 weeks, then 40 mg daily for another 4 weeks
Trial: 30113651
Drug: Dapagliflozin at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin at 10 mg
Trial: 30113651
Drug: Empagliflozin at
RxNorm normalized name: Empagliflozin
DrugBank: Empagliflozin (DB09038)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Empagliflozin at 10 mg
Trial: 12826169
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (vitamin D plus calcium at the same dose)
Trial: 8799780
Drug: Single 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 1 g oral dose of azithromycin (Group A)
Trial: 8799780
Drug: Standard duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard duration therapy (Group S)
Trial: 1386071
Drug: Fenoterol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.1 mg/kg) plus ipratropium bromide (50 micrograms)
Trial: 1386071
Drug: Fenoterol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.1 mg/kg) and placebo
Trial: 6364761
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy (CABG)
Trial: 30821649
Drug: Telephone-based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based Cognitive Behavioral Therapy (CBT)
Trial: 29730798
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment without a nerve block)
Trial: 27543364
Drug: Melatonin cream
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin cream 12.5%
Trial: 27543364
Drug: Melatonin cream
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin cream 0.5%
Trial: 27543364
Drug: Melatonin cream
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin cream 2.5%
Trial: 24629911
Drug: Dietary olestra
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary olestra (15 g/day)
Trial: 10071177
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of d‐Fenfluramine (d‐Fen)
Trial: 10071177
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of Ipsapirone (Ips)
Trial: 8868007
Drug: Roxatidine 150
RxNorm normalized name: roxatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine 150 mg
Trial: 2347956
Drug: Ceftriaxone 0.5
RxNorm normalized name: CEFTRIAXONE 0.5GM/VIL/LIDOCAIN 1% IJ KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 0.5 g IV without probenecid
Trial: 23135
Drug: Chlordiazepoxide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlordiazepoxide (30 mg orally)
Trial: 31404033
Drug: Photobiomodulation (PBM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation (PBM) treatment using the Valeda Light Delivery System, 3 times per week for 3-4 weeks over 1 year.
Trial: 31404033
Drug: Photobiomodulation (PBM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation (PBM) treatment
Trial: 26497059
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol (Group C)
Trial: 15975964
Drug: Adalimumab (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (40 mg every 2 weeks, subcutaneously) for 12 months
Trial: 12874091
Drug: Valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (160 mg/d) administered in the morning
Trial: 16144987
Drug: Valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (160 mg/d) administered at bedtime
Trial: 12874091
Drug: Valsartan administered
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan administered at bedtime
Trial: 12874091
Drug: Valsartan administered
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan administered in the morning vs bedtime
Trial: 10859151
Drug: Oral tablet
RxNorm normalized name: Oral Tablet
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tablet dosing of rosiglitazone
Trial: 10859151
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations of rosiglitazone
Trial: 8026109
Drug: Fish-oil product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil product with a high percentage of omega-3-polyunsaturated fatty acids (K 85, 6g daily)
Trial: 8026109
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (6g daily)
Trial: 21183763
Drug: Conventional strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional strategy (325 mg aspirin orally and a loading dose of 600 mg clopidogrel)
Trial: 10882149
Drug: Cyclical etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclical etidronate therapy
Trial: 2858749
Drug: Nightly oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nightly oral formula supplements
Trial: 22592929
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg misoprostol vaginally 12 hours before hysteroscopy
Trial: 31549577
Drug: Spironolactone, 50
RxNorm normalized name: Spironolactone, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone, 50 mg orally once daily for 12 months
Trial: 31549577
Drug: Eplerenone, 50
RxNorm normalized name: Eplerenone, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone, 50 mg orally once daily for 12 months
Trial: 28686777
Drug: Topical dapsone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dapsone gel, 7.5%
Trial: 23663063
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (20 Gy) of Gamma knife radiosurgery
Trial: 23663063
Drug: Gamma knife
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma knife radiosurgery (both doses)
Trial: 21875223
Drug: Nicotine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (6 mg)